Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A

Blood

Volumn 118, Issue 12, 2011, Pages 3340-3346

  Preuss, Klaus Dieter ^a   Pfreundschuh, Michael ^a   Fadle, Natalie ^a   Regitz, Evi ^a   Raudies, Sybille ^a   Murwaski, Niels ^a   Ahlgrimm, Manfred ^a   Bittenbring, Joerg ^a   Klotz, Markus ^b   Schäfer, Karl Herbert ^b   Held, Gerhard ^a   Neumann, Frank ^a   Grass, Sandra ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES KAISERSLAUTERN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; PARAPROTEIN; PARATARG 7; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE C LAMBDA; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

EID: 80053181515     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-04-351668     Document Type: Article

References (20)

1. Preuss KD, Pfreundschuh M, Ahlgrimm M, et al. A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS. Int J Cancer. 2009;125(3):656-661.
2. Grass S, Preuss KD, Wikowicz A, et al. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia. Blood. 2011; 117(10):2918-2923.
3. Grass S, Preuss K-D, Ahlgrimm A, et al. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study. Lancet Oncol. 2009;10(10):950-956.
4. Grass S, Preuss K-D, Pfreundschuh M. Autosomal-dominant inheritance of hyperphosphorylated paratarg-7. Lancet Oncol. 2010;11(1):12.
5. Grass S, Iida S, Wikowicz A, et al. Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma. Cancer Sci. 2011; 102(3):565-568.
6. Lynch HT, Ferrara K, Barlogie B, et al. Familial myeloma. N Engl J Med. 2008;359(2):152-157. (Pubitemid 351962038)
7. Grass S, Preuss K-D, Thome S, et al. Paraproteins of familial MGUS/mulitple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sproadic MGUS/MM. Blood. 2011;118(3):635-637.
8. Neumann F, Wagner C, Preuss KD, et al. Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cells. Blood. 2005;106(9):3105-3113. (Pubitemid 41565907)
9. Konigshoff M, Wilhelm J, Bohle RM, Pingoud A, Hahn M. HER-2/neu gene copy number quantified by real-time PCR: comparison of gene amplification, heterozygosity, and immunohistochemical status in breast cancer tissue. Clin Chem. 2003;49(2):219-229. (Pubitemid 36143442)
10. Hamilton CK, Favetta LA, Di Meo GP, et al. Copy number variation of testis-specific protein, Y-encoded (TSPY) in 14 different breeds of cattle (Bos taurus). Sex Dev. 2009;3(4):205-213.
11. Rush J, Moritz A, Lee KA, et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol. 2005;23(1):94-101. (Pubitemid 41724631)
12. Calbiochem Inhibitor Sourcebook. Darmstadt, Germany: Merck KGaA; 2009.
13. Theodore L, Derossi D, Chassaing G, et al. Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse. J Neurosci. 1995;15(11):7158-7167.
14. Zolnierowicz S, Van HC, Andjelkovic N, et al. The variable subunit associated with protein phosphatase 2A0 defines a novel multimember family of regulatory subunits. Biochem J. 1996;317(Pt 1): 187-194.
15. Chen J, Martin BL, Brautigan DL. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science. 1992; 257(5074):1261-1264.
16. Guo H, Damuni Z. Autophosphorylation-activated protein kinase phosphorylates and inactivates protein phosphatase 2A. Proc Natl Acad Sci U S A. 1993;90(6):2500-2504. (Pubitemid 23078655)
17. Janssens V, Longin S, Goris J. PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends Biochem Sci. 2008;33(3):113-121.
18. Glaser ND, Lukyanenko YO, Wang Y, Wilson GM, Rogers TB. JNK activation decreases PP2A regulatory subunit B56alpha expression and mRNA stability and increases AUF1 expression in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2006;291(3):H1183-H1192. (Pubitemid 44343662)
19. Ahn JH, McAvoy T, Rakhilin SV, et al. Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56delta subunit. Proc Natl Acad Sci U S A. 2007;104(8):2979-2984. (Pubitemid 46327989)
20. Xing Y, Li Z, Chen Y, et al. Structural mechanism of demethylation and inactivation of protein phosphatase 2A. Cell. 2008;133(1):154-163. (Pubitemid 351442993)